Condensed Consolidated Statements of Earnings - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Dec. 31, 2017
Revenue	$ 37,740	$ 35,186	$ 72,953	$ 67,827
Cost of products sold	36,010	33,325	69,556	64,294
Gross margin	1,730	1,861	3,397	3,533
Operating expenses:
Distribution, selling, general and administrative expenses	1,064	1,131	2,219	2,193
Restructuring and employee severance	12	21	44	153
Amortization and other acquisition-related costs	157	184	314	368
Impairments and (gain)/loss on disposal of assets, net	8	68	(503)	68
Litigation (recoveries)/charges, net	(15)	58	3	90
Operating earnings	504	399	1,320	661
Other (income)/expense, net	21	(5)	25	(4)
Interest expense, net	76	87	152	168
Loss on Extinguishment of Debt	0	0	0	2
Earnings before income taxes	407	317	1,143	495
Provision for/(benefit from) income taxes	126	(736)	269	(675)
Net earnings	281	1,053	874	1,170
Net earnings attributable to noncontrolling interests	(1)	0	(1)	(2)
Net earnings attributable to Cardinal Health, Inc.	$ 280	$ 1,053	$ 873	$ 1,168
Earnings per common share attributable to Cardinal Health, Inc.:
Basic (in shares)	$ 0.94	$ 3.35	$ 2.90	$ 3.70
Income (Loss) from Continuing Operations, Per Diluted Share	$ 0.93	$ 3.33	$ 2.88	$ 3.68
Weighted-average number of common shares outstanding:
Basic (in shares)	299	315	302	315
Diluted (in shares)	300	316	303	317
Cash dividends declared per common share	$ 0.4763	$ 0.4624	$ 0.9526	$ 0.9248